NIRF / PA bimodal probe based on NTR response as well as preparation method and application of NIRF / PA bimodal probe
By developing the NIRF/PA dual-mode probe SiRho-SHD-NTR based on NTR response, using the FRET dual-mode ratio signal detection strategy, the problems of slow response speed and insufficient anti-interference ability of the existing probe signal are solved, and the problem of slow response speed and insufficient anti-interference ability is realized. Rapid, highly sensitive detection of NTR and pancreatic cancer imaging, suitable for surgical navigation and imaging.
Patent Information
- Application Number
- CN202411214622.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-01
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-09-01
AI Technical Summary
The existing fluorescence/photoacoustic probes are not effective for high sensitivity detection and high contrast imaging of intratumor NTR, and are not effective for pancreatic cancer imaging-mediated surgical treatment, mainly due to the slow signal response speed and insufficient anti-interference ability.
A NIRF/PA dual-mode probe SiRho-SHD-NTR based on NTR response was developed. Through the FRET dual-mode ratio signal detection strategy, the probe has strong fluorescence and photoacoustic signals at 680nm, and fluorescence and light after reaction with NTR. The acoustic signal is enhanced at 740nm and 760nm, achieving ratio-based detection, with fast response and high selectivity.
It realizes rapid and highly sensitive detection of NTR, can overcome biological background signal interference, improve imaging accuracy and sensitivity, and is suitable for surgical navigation and imaging of pancreatic cancer and metastatic tumors.
Smart Images

Figure CN119080819A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a NIRF / PA dual-mode probe based on NTR response and a preparation method and application thereof, belonging to the technical field of biomedicine. Background Art
[0002] Nitroreductase (NTR) plays an important role in the detection and imaging of malignant tumors as an important marker of tumor hypoxia. Hypoxia is one of the specific markers of the tumor microenvironment and is closely related to the development and metastasis of cancer. The hypoxic microenvironment not only promotes the proliferation and invasion of tumor cells, but also reduces the sensitivity of tumors to chemotherapy, radiotherapy and photodynamic therapy, seriously affecting the effect of cancer treatment. As an important marker of tumor hypoxia, the expression of NTR is closely related to the degree of tumor hypoxia.
[0003] So far, many fluorescent probes have been reported for the detection of NTR, however, these probes are generally single-channel enhanced probes. In order to solve the problems of insufficient penetration depth of near-infrared fluorescence (NIRF) and low sensitivity of photoacoustic (PA) imaging probes, it is of great significance to develop ratiometric NIRF / PA dual-modality probes. PA imaging can diagnose and locate tumors non-invasively before surgery, while NIRF can accurately image pancreatic cancer tissue and micrometastases during intraoperative surgical navigation. This multimodal imaging strategy meets the multifaceted needs of detection and treatment of different stages of cancer and minimizes external interference. In addition, most fluorescent probes respond slowly to NTR, usually taking more than 20 minutes. Considering the clinical needs for rapid pathological evaluation and fluorescence-guided tumor resection, fluorescent probes that can respond quickly to NTR are particularly important for bedside pathological diagnosis and intraoperative surgical navigation.
[0004] NTR probes must meet the following requirements to achieve accurate imaging of pancreatic cancer by responding to tumor hypoxia levels: high penetration depth, high imaging resolution, 3D spatial imaging, rapid response, and excellent selectivity. In addition, given the complex microenvironment within the tumor, the probe must have strong anti-interference and self-calibration capabilities to significantly reduce false positive signals caused by interfering substances. Therefore, it is crucial to develop a NIRF / PA dual-modality probe that meets the above requirements. Summary of the invention
[0005] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a NIRF / PA dual-modal probe based on NTR response and its preparation method and application, so as to solve the problems that the existing fluorescence / photoacoustic probes cannot be effectively used for high-sensitivity detection and high-contrast imaging of NTR in tumors due to high biological background fluorescence / photoacoustic signals and slow NTR response speed, and cannot be effectively used for imaging-mediated surgical treatment of pancreatic cancer.
[0006] The present invention also provides a NIRF / PA dual-modality probe (SiRho-SHD-NTR) based on NTR response, and the structural formula of the probe is as follows:
[0007]
[0008] The mechanism of the probe (SiRho-SHD-NTR) for detecting nitroreductase is as follows:
[0009]
[0010] The present invention also provides a method for preparing the NIRF / PA dual-modality probe based on NTR response, comprising the following steps:
[0011] (1) Compound 1 is dissolved in anhydrous acetonitrile and transferred to a round-bottom flask under an inert atmosphere, and then phosphorus oxychloride is slowly added to the reaction system. The mixture is stirred to react at a set temperature. After the reaction is completed, the solvent is removed by rotary evaporation to obtain Compound 2;
[0012] (2) 1-Boc-piperazine and compound 2 were dissolved in anhydrous acetonitrile, and triethylamine was then slowly added. The reaction mixture was stirred at room temperature and concentrated under reduced pressure. Compound 3 was obtained after extraction and purification.
[0013] (3) Compound 3 was dissolved in a mixture of trifluoroacetic acid and dichloromethane, and the mixture was stirred at room temperature for reaction. After the reaction was completed, the solvent was removed by rotary evaporation, and the round-bottom flask was placed in a vacuum drying oven overnight to obtain Compound 4;
[0014] (4) Compound 5 and 3-hydroxythiophenol are dissolved in anhydrous N,N-dimethylformamide under an inert atmosphere, and then triethylamine is added and stirred to react at a predetermined temperature. After the reaction is completed, the reaction mixture is diluted with dichloromethane, and washed and extracted with a saturated sodium chloride solution for multiple times, and then dried, rotary evaporated to remove the solvent and purified to obtain Compound 6;
[0015] (5) Compound 6 was dissolved in methanol, and then concentrated hydrochloric acid was added and stirred for reaction at room temperature. After the reaction was completed, compound 7 was obtained;
[0016] (6) Compound 7 was dissolved in dichloromethane, and then acetic anhydride and triethylamine were added in sequence, and the mixture was reacted at room temperature. After the reaction was completed, the reaction mixture was washed and extracted with a saturated sodium chloride solution for multiple times, and then dried, rotary evaporated to remove the solvent, and purified to obtain compound 8;
[0017] (7) Compound 4 and Compound 8 were dissolved in dichloromethane, and then HATU and DIPEA were added in sequence, and the reaction was stirred at room temperature. After the reaction was completed, the reaction mixture was washed and extracted with a saturated sodium chloride solution for multiple times, and then dried, rotary evaporated to remove the solvent and purified to obtain Compound 9;
[0018] (8) Compound 9 was dissolved in methanol, and then concentrated hydrochloric acid was added and stirred for reaction at room temperature. After the reaction was completed, a dye (SiRho-SHD-OH) was obtained;
[0019] (9) dissolving the dye obtained in step (8) in anhydrous N,N-dimethylformamide, then adding potassium carbonate and sodium iodide, stirring the reaction at a set temperature, adding a tetrahydrofuran solution of p-nitrobenzyl bromide under an inert atmosphere after the reaction, and stirring at room temperature overnight, then washing and extracting the reaction mixture with a saturated sodium chloride solution for multiple times, and then drying, rotary evaporation to remove the solvent and purifying to obtain a NIRF / PA dual-modal probe based on NTR response (SiRho-SHD-NTR);
[0020] The reaction formula is:
[0021]
[0022] In step (1), the molar ratio of compound 1 to phosphorus oxychloride is 1:(0.5-1).
[0023] In step (2), the molar ratio of compound 2, 1-Boc-piperazine and triethylamine is 1:(1.5-2):(1.5-2).
[0024] In step (3), the amount of compound 3 added is 0.1-0.4 mmol, the volume ratio of trifluoroacetic acid and dichloromethane is 1:(4.0-5.0), and the total volume of the solvent is 20-30 mL.
[0025] In step (4), the molar ratio of compound 5, 3-hydroxythiophenol and triethylamine is 1:(1.2-1.5):(1.2-1.5).
[0026] In step (5), the molar ratio of compound 6 to concentrated hydrochloric acid is 1:(3-5), and the mass fraction of concentrated hydrochloric acid is 36-38%.
[0027] In step (6), the molar ratio of compound 7, acetic anhydride and triethylamine is 1:(1.2-1.5):(1.2-1.5).
[0028] In step (7), the molar ratio of compound 4, compound 8, HATU and DIPEA is 1:(1.1-1.2):(1.2-1.5):(2-3).
[0029] In step (8), the molar ratio of compound 9 to concentrated hydrochloric acid is 1:(3-5), and the mass fraction of concentrated hydrochloric acid is 36-38%.
[0030] In step (9), the molar ratio of the dye, p-nitrobenzyl bromide, potassium carbonate and sodium iodide is 1:(1.1-1.3):(1.5-2):(2-3).
[0031] The present invention also provides the application of the NIRF / PA dual-modality probe based on NTR response, which is used to detect NTR in samples, cells, tissues and living mice.
[0032] The present invention also provides a detection solution of the NIRF / PA dual-modal probe based on NTR response, and the preparation process is:
[0033] The probe is dissolved in dimethyl sulfoxide and then added into a DPBS buffer solution, the probe concentration is 5-10 μM, and the volume ratio of dimethyl sulfoxide is 1-30%.
[0034] When the probe concentration is 5-10 μM and the volume ratio of dimethyl sulfoxide is 10%, the best test effect can be obtained.
[0035] The present invention proposes a dual-mode ratio signal detection strategy for NTR based on FRET, and designs a NIRF / PA dual-mode ratio probe SiRho-SHD-NTR, which has a strong fluorescence (FL) at 680nm. 680nm ) and photoacoustic (PA 680nm ) signal. When the probe reacts with NTR, the fluorescence emission and photoacoustic signal of the FRET system receptor are enhanced. 740nm ) signal is enhanced, and the fluorescence (FL 760nm ) signal is enhanced, while FL 680nm and PA 680nmRemaining unchanged, ratiometric fluorescence / photoacoustic signal detection of NTR can be achieved. And the probe has a strong interaction with the NTR enzyme, and molecular docking simulation shows that the binding energy between NTR and the probe is -9.279 kcal / mol (usually a value lower than -7 kcal / mol indicates a strong binding affinity). It is worth noting that the lower affinity value indicates that the binding energy between the probe and NTR is lower, making it easier for NTR to dissociate from the reduced probe and participate in the subsequent catalytic process, confirming the rapid response ability of the probe and NTR, which is beneficial to the imaging of living tumors and intraoperative surgical navigation applications. Therefore, the probe realizes rapid, highly sensitive detection of NTR in living tumors and near-infrared fluorescence / photoacoustic dual-modal ratio imaging. The present invention can well overcome the interference of biological background fluorescence / photoacoustic signals, and is expected to improve the accuracy and sensitivity of in vivo imaging analysis of NTR, and be applied to surgical navigation of pancreatic cancer and metastatic tumors.
[0036] The beneficial technical effects of the present invention are:
[0037] 1) The NIRF / PA dual-modal probe based on NTR response can respond to NTR quickly, with response saturation in about 5 minutes, good selectivity for nitroreductase, and high sensitivity (detection limit 50 ng / mL);
[0038] 2) The probe absorbs and emits in the near infrared, which can effectively overcome the interference of biological background signals;
[0039] 3) The probe is a fluorescence / photoacoustic dual-mode ratiometric probe that can achieve self-correction during the imaging of biological systems and improve imaging accuracy;
[0040] 4) The probe achieved near-infrared fluorescence / photoacoustic dual-modality ratio imaging of pancreatic cancer tumors in mice, reflecting the clinical application prospects of imaging-mediated pancreatic cancer tumor surgery of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 The UV spectrum (a) and fluorescence spectrum (b) of the probe SiRho-SHD-NTR in response to 0-20 μg / mL NTR.
[0042] Figure 2 The photoacoustic full spectrum of the probe SiRho-SHD-NTR in response to NTR (a), the photoacoustic intensity quantification diagram after the probe responds to 0-20 μg / mL NTR (b, c) and its photoacoustic imaging diagram (d). The inset is the linear relationship diagram of the photoacoustic ratio signal of the probe in response to low concentration NTR.
[0043] Figure 3 The photoacoustic selectivity image (a), photoacoustic ratio signal selectivity (b), fluorescence selectivity (c) and chemical kinetic curve (d) of the probe SiRho-SHD-NTR.
[0044] Figure 4 Confocal imaging of intracellular NTR using the probe SiRho-SHD-NTR (a), schematic diagram of the mechanism of cobalt chloride-induced cell hypoxia (b), and quantification bar graph of cell fluorescence ratio signal (c).
[0045] Figure 5 The figures are the ratiometric photoacoustic imaging image of the probe SiRho-SHD-NTR for living tumors (a), the photoacoustic intensity quantification images of the tumor area (b) and normal tissue (c), and the photoacoustic ratio signal quantification bar graph of the tumor area and normal tissue (d).
[0046] Figure 6 The photoacoustic scanning images of each section of a living tumor using the probe SiRho-SHD-NTR (a), and the photoacoustic ratio signal quantification images of each section of normal tissue (b) and tumor area (c).
[0047] Figure 7 Schematic diagram of the experimental model for ratiometric near-infrared fluorescence imaging of living tumors by the probe SiRho-SHD-NTR (a), ratiometric near-infrared fluorescence imaging (b), quantification of near-infrared fluorescence intensity of normal tissue (c) and tumor area (d), and quantification of near-infrared fluorescence ratio signals of tumor area and normal tissue (e).
[0048] Figure 8 This is the near-infrared fluorescence imaging of in situ tumors in vivo using the probe SiRho-SHD-NTR by spraying.
[0049] Fig. 9 This is the detection principle of the probe SiRho-SHD-NTR. DETAILED DESCRIPTION
[0050] The present invention is further described below with reference to specific examples, but the present invention is not limited to the following examples. The methods are conventional methods unless otherwise specified, and the raw materials can be obtained from public commercial channels unless otherwise specified.
[0051] Example 1
[0052] Synthesis of probe SiRho-SHD-NTR
[0053] (1) Compound 1 was dissolved in 50 mL of anhydrous acetonitrile, placed in a 250 mL round-bottom flask, and operated under nitrogen protection. Then 2 mL of phosphorus oxychloride was slowly added to the reaction system. The mixture was stirred at 88° C. for 5 hours. After the reaction was completed, the solvent was removed by rotary evaporation without further purification to obtain compound 2;
[0054] (2) 1-Boc-piperazine and compound 2 were dissolved in 50 mL of anhydrous acetonitrile. Then 1 mL of triethylamine was slowly added to the reaction system and stirred at room temperature for 30 minutes. The mixture was concentrated under reduced pressure and extracted with saturated sodium chloride solution and dichloromethane. Subsequently, dichloromethane-ethanol was used as the mobile phase, and the crude product was separated and purified by column chromatography to obtain compound 3;
[0055] (3) Compound 3 was dissolved in a mixture of trifluoroacetic acid and dichloromethane in a volume ratio of 1: (4.0-5.0) and stirred at room temperature for 2 hours. After the reaction was completed, the solvent was removed by rotary evaporation and the round-bottom flask was placed in a vacuum drying oven overnight. Compound 4 was obtained without further purification;
[0056] (4) Compound 5 and 3-hydroxyphenol were dissolved in 50 mL of anhydrous N,N-dimethylformamide under a nitrogen atmosphere. When the reactants were dissolved, 1 mL of triethylamine was slowly added and the reaction was stirred at 60°C for 8 hours. After the reaction was completed, the reaction mixture was diluted with 50 mL of dichloromethane and washed and extracted with a saturated sodium chloride solution for multiple times. The aqueous phase was discarded and the organic phase was retained. Anhydrous sodium sulfate was then added to the organic phase and evaporated under reduced pressure to obtain a crude product. The crude product was separated and purified by column chromatography using dichloromethane-methanol as the mobile phase to obtain compound 6;
[0057] (5) Compound 6 was dissolved in 30 mL of methanol and placed in a round-bottom flask. Then 5 mL of concentrated hydrochloric acid was added and stirred for 2 hours. After the reaction was completed, methanol was removed by evaporation under reduced pressure. The residue was washed and extracted three times with 50 mL of dichloromethane and saturated brine, and the organic phase was collected, dried over anhydrous sodium sulfate, and then rotary evaporated to obtain a crude product. Finally, dichloromethane-methanol was used as the mobile phase, and compound 7 was separated and purified by column chromatography;
[0058] (6) Compound 7 was dissolved in 30 mL of dichloromethane, and then 1 mL of acetic anhydride and 1 mL of triethylamine were added. The mixture was reacted at room temperature for 2 hours. After the reaction was completed, the reaction mixture was washed with saturated brine and extracted three times. The organic phase was collected and dried over anhydrous sodium sulfate. The solvent was removed by evaporation under reduced pressure to obtain a crude product. The crude product was separated and purified by column chromatography using dichloromethane-methanol as the mobile phase to obtain compound 8;
[0059] (7) Compound 4 and Compound 8 were dissolved in 30 mL of dichloromethane. Then, 2 mL of HATU and 100 mg of DIPEA were added in sequence, and the mixture was stirred at room temperature for two hours. After the reaction was completed, the mixture was washed with saturated brine and extracted three times. Then, the mixture was dried with anhydrous sodium sulfate and the solvent was removed by rotary evaporation to obtain Compound 9 without further purification.
[0060] (8) Compound 9 was dissolved in 30 mL of methanol, and 5 mL of concentrated hydrochloric acid was added, and the reaction was stirred for 2 hours. After the reaction was completed, methanol was removed by evaporation under reduced pressure. The residue was washed and extracted three times with 50 mL of dichloromethane and saturated brine, and the organic phase was collected, dried over anhydrous sodium sulfate, and then rotary evaporated to obtain a crude product. Finally, the dye SiRho-SHD-OH was separated and purified by column chromatography using dichloromethane-methanol as the mobile phase;
[0061] Structure of dye SiRho-SHD-OH:
[0062]
[0063] Mass spectrometry and NMR characterization of dye SiRho-SHD-OH:
[0064] 1 H NMR (500MHz, DMSO-d6) δ9.92(s,1H),8.20(d,J=14.2Hz,2H),7.77(d,J=7.4Hz,2H),7.68(d,J=8.0Hz,2H),7.57-7.52(t,J= 7.55Hz,2H),7.45(t,J=7.5Hz,2H),7.39(s,2H),7.19(d,J=1.9Hz,2H),6.97(m,1H),6.95(m,1H),6.90(d,J=7.7Hz,1H),6. 69(d,J=8.1Hz,1H),6.62(d,J=14.3Hz,2H),4.40(t,J=7.0Hz,4H),3.55(s,12H),2.76-2.69(m,4H),2.66(t,J=5.6Hz,4H), 2.31(t,J=7.3Hz,4H),1.75(s,6H),1.63-1.54(m,4H),1.46-1.36(m,3H),1.13(t,J=7.1Hz,2H),1.05(s,3H),0.85(s,3H);
[0065] ESI-MS: calculated for C 61 H 69 N5O3SSi 2+ [M] 2+ ,489.7440;Found,490.12.
[0066] (9) The dye SHD-SiRho-OH was dissolved in anhydrous N,N-dimethylformamide (1.5 mL), and then potassium carbonate and sodium iodide were added and stirred at 40°C for 10 minutes. Subsequently, p-nitrobenzyl bromide dissolved in anhydrous tetrahydrofuran was added and stirred overnight under a nitrogen atmosphere. After the reaction, it was washed and extracted three times with 50 mL of dichloromethane and saturated sodium chloride, the organic phase was collected, dried with anhydrous sodium sulfate, and then evaporated under reduced pressure to remove the solvent to obtain a crude product. Finally, the probe SiRho-SHD-NTR was separated and purified by column chromatography using dichloromethane-methanol as the mobile phase to obtain a blue-purple solid.
[0067] The structure of the probe SiRho-SHD-NTR:
[0068]
[0069] Mass spectrometry and NMR characterization of probe SiRho-SHD-NTR:
[0070] 1 H NMR (500MHz, CDCl3) δ8.43(s,1H),8.28(d,J=6.1Hz,2H),7.71(s,2H),7.57(d,J=8.6Hz,2H),7.47(d,J=8.6Hz,2H),7 .39(s,2H),7.17(dd,J=8.5,2.4Hz,2H),7.08(d,J=8.6Hz,1H),6.87(t,J=13.1Hz,1H),6.37-6.26(m,2H),6.16(d,J= 16.2Hz,2H),4.32(s,2H),3.67(d,J=18.4Hz,8H),3.54(d,J=12.2Hz,2H),2.85(s,3H),2.80(s,2H),2.47(s,2H),2.4 2-2.35(m,2H),2.30-2.22(m,2H),2.05(d,J=5.8Hz,6H),1.71-1.59(m,12H),1.52(s,3H),1.07(s,9H),0.92(s,2H).
[0071] 13C NMR(126MHz,DMSO-d6)δ178.19,171.01,165.59,159.45,153,94,151.65,147,38,144.60,141.75,135.35,1 28.83,124.14,121.67,110.40,69.14,55.40,51.15,45.72,31.60,29.48,27.99,25.12,22.54,14.40,8.84.
[0072] ESI-MS: calculated for C 68 H 74 N6O5SSi 2+ [M] 2+ ,557.2600;Found,557.68.
[0073] Example 2
[0074] Detection of NTR by probe SiRho-SHD-NTR in buffer system
[0075] Dissolve 11.16 mg of the probe in 10 mL of DMSO to prepare a 1 mM stock solution, and store it at -20°C. The detection system is DPBS buffer solution (10 mM, pH 7.4, containing 10% DMSO). Shake the reaction system of the probe SiRho-SHD-NTR and NTR at room temperature for 30 minutes, and then measure its fluorescence emission and UV-visible absorption spectrum. Set the excitation wavelength of the fluorescence instrument to 650 nm and 730 nm, and the emission wavelength receiving range to 660-740 nm and 740-840 nm. Set the measurement range of the absorption spectrum to 500-800 nm. The results are as follows Figure 1 As shown, from Figure 1 It can be seen that the probe SiRho-SHD-NTR has a good response to NTR, the near-infrared fluorescence spectrum shows nearly 18-fold fluorescence enhancement, and both the absorption spectrum and the fluorescence spectrum show ratiometric changes.
[0076] The experimental steps of the photoacoustic response of the probe SiRho-SHD-NTR to NTR in the buffer system are the same as those of the absorption spectrum. The sample after the reaction is placed in a photoacoustic imager to measure the photoacoustic spectrum of the sample. The results are shown in Figure 2 As shown, from Figure 2 It can be seen that the probe SiRho-SHD-NTR has a good photoacoustic response to NTR, and the photoacoustic response result is similar to the absorption spectrum.
[0077] Example 3
[0078] Investigation of the detection selectivity and chemical kinetics of NTR by probe SiRho-SHD-NTR in buffer system
[0079] Dissolve 11.16 mg of the probe in 10 mL of DMSO to prepare a 1 mM stock solution and store it at -20°C. The detection system is a DPBS buffer solution (10 mM, pH 7.4, containing 10% DMSO). Shake the reaction system of the probe SiRho-SHD-NTR, NTR and various test substances at room temperature for 15 minutes, and then measure its fluorescence emission spectrum and photoacoustic imaging. Set the excitation wavelength of the fluorescence instrument to 650 nm and 730 nm, and the emission wavelength receiving range to 660-740 nm and 740-840 nm. The results are as follows Figure 3 As shown in ac, from Figure 3 As can be seen from Figure ac, the probe SiRho-SHD-NTR has good selectivity for NTR, and GSH, Hcy and other factors have little interference. Figure 3 As shown in d, the probe SiRho-SHD-NTR has a very fast reaction rate to NTR, and basically reaches the reaction platform in about 5 minutes.
[0080] Example 4
[0081] Imaging detection of intracellular NTR using probe SiRho-SHD-NTR
[0082] 11.16 mg of the probe was dissolved in 10 mL of DMSO to prepare a 1 mM stock solution, which was stored at -20°C. 5 μL of the probe was incubated in the cells, and the confocal microscope was set to an excitation wavelength of 640 nm and an emission wavelength receiving range of 650-750 nm and 720-780 nm. The results are shown in Figure 2. Figure 4 As shown, from Figure 4 It can be seen that the probe SiRho-SHD-NTR has a good response to the nitroreductase content induced by cobalt chloride in cells, and the imaging contrast is very high.
[0083] Example 5
[0084] Photoacoustic imaging detection of NTR in living tumors and tumor cross-sections using probe SiRho-SHD-NTR
[0085] Dissolve 11.16 mg of the probe in 10 mL of DMSO to prepare a 1 mM stock solution and store it at -20°C. Prepare the probe to 200 μM and dissolve it in DPBS / DMSO, v / v=7:3, pH 7.4. Take 20 μL of the probe solution and inject it into the tumor, and then perform small animal photoacoustic imaging. Set the excitation wavelength of the small animal photoacoustic imager to 680 and 740 nm. The results are shown in Figure 5 As shown, from Figure 5It can be seen that the probe SiRho-SHD-NTR has a good response to NTR in the tumor, and the photoacoustic ratio imaging contrast is very high. Figure 6 It can be seen that the probe SiRho-SHD-NTR has a good response to NTR in each section of the tumor, and the photoacoustic ratio imaging contrast is very high.
[0086] Example 6
[0087] Near-infrared fluorescence imaging detection of NTR in living tumors using probe SiRho-SHD-NTR
[0088] Dissolve 11.16 mg of the probe in 10 mL of DMSO to prepare a 1 mM stock solution and store it at -20°C. Prepare the probe to 200 μM and dissolve it in DPBS / DMSO, v / v=7:3, pH 7.4. Take 20 μL of the probe solution and inject it into the tumor, and then perform in vivo fluorescence imaging of small animals. Set the excitation wavelength of the fluorescence instrument to 640 nm and 740 nm, and the emission wavelength receiving range to 650-700 nm and 750-800 nm. The results are as follows Figure 7 As shown, from Figure 7 It can be seen that the probe SiRho-SHD-NTR has a good response to NTR in the tumor, and the near-infrared fluorescence ratio imaging has a high contrast.
[0089] Example 7
[0090] Near-infrared fluorescence imaging detection of in situ tumors in vivo by spraying probe SiRho-SHD-NTR
[0091] Dissolve 11.16 mg of the probe in 10 mL of DMSO to prepare a 1 mM stock solution and store it at -20°C. Prepare the probe to 200 μM and dissolve it in DPBS / DMSO, v / v=7:3, pH 7.4. Take 2 mL of the probe solution and place it in a 3 mL small spray bottle, spray it on the dissected mice with in situ tumors, and then perform in vivo fluorescence imaging of the small animals. Set the excitation wavelength of the fluorescence instrument to 640 nm and 740 nm, and the emission wavelength receiving range to 650-700 nm and 750-800 nm. The results are as follows Figure 8 As shown, from Figure 8 It can be seen that the probe SiRho-SHD-NTR has a good response to NTR in situ tumors, and the near-infrared fluorescence ratio imaging contrast is very high. The detection principle is as follows Fig. 9 shown.
[0092] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A NIRF / PA dual-modality probe based on NTR response, It is characterized in that The structural formula of the probe is as follows:
2. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 1, It is characterized in that The following steps are involved: (1) Compound 1 is dissolved in anhydrous acetonitrile and transferred to a round-bottom flask under an inert atmosphere, and then phosphorus oxychloride is slowly added to the reaction system. The mixture is stirred to react at a set temperature. After the reaction is completed, the solvent is removed by rotary evaporation to obtain Compound 2; (2) 1-Boc-piperazine and compound 2 were dissolved in anhydrous acetonitrile, and triethylamine was then slowly added. The reaction mixture was stirred at room temperature and concentrated under reduced pressure. Compound 3 was obtained after extraction and purification. (3) Compound 3 was dissolved in a mixture of trifluoroacetic acid and dichloromethane, and the mixture was stirred at room temperature for reaction. After the reaction was completed, the solvent was removed by rotary evaporation, and the round-bottom flask was placed in a vacuum drying oven overnight to obtain Compound 4; (4) Compound 5 and 3-hydroxythiophenol are dissolved in anhydrous N,N-dimethylformamide under an inert atmosphere, and then triethylamine is added and stirred to react at a predetermined temperature. After the reaction is completed, the reaction mixture is diluted with dichloromethane, and washed and extracted with a saturated sodium chloride solution for multiple times, and then dried, rotary evaporated to remove the solvent and purified to obtain Compound 6; (5) Compound 6 was dissolved in methanol, and then concentrated hydrochloric acid was added and stirred for reaction at room temperature. After the reaction was completed, compound 7 was obtained; (6) Compound 7 was dissolved in dichloromethane, and then acetic anhydride and triethylamine were added in sequence, and the mixture was reacted at room temperature. After the reaction was completed, the reaction mixture was washed and extracted with a saturated sodium chloride solution for multiple times, and then dried, rotary evaporated to remove the solvent, and purified to obtain compound 8; (7) Compound 4 and Compound 8 were dissolved in dichloromethane, and then HATU and DIPEA were added in sequence, and the reaction was stirred at room temperature. After the reaction was completed, the reaction mixture was washed and extracted with a saturated sodium chloride solution for multiple times, and then dried, rotary evaporated to remove the solvent and purified to obtain Compound 9; (8) dissolving compound 9 in methanol, then adding concentrated hydrochloric acid, stirring and reacting at room temperature, and obtaining a dye after the reaction is completed; (9) dissolving the dye obtained in step (8) in anhydrous N,N-dimethylformamide, then adding potassium carbonate and sodium iodide, stirring the reaction at a set temperature, adding a tetrahydrofuran solution of p-nitrobenzyl bromide under an inert atmosphere after the reaction, and stirring at room temperature overnight, then washing and extracting the reaction mixture with a saturated sodium chloride solution for multiple times, and then drying, rotary evaporation to remove the solvent and purifying to obtain a NIRF / PA dual-modal probe based on NTR response; The reaction formula is:
3. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (1), the molar ratio of compound 1 to phosphorus oxychloride is 1:(0.5-1).
4. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (2), the molar ratio of compound 2, 1-Boc-piperazine and triethylamine is 1:(1.5-2):(1.5-2).
5. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (3), the amount of compound 3 added is 0.1-0.4 mmol, the volume ratio of trifluoroacetic acid and dichloromethane is 1:(4.0-5.0), and the total volume of the solvent is 20-30 mL.
6. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (4), the molar ratio of compound 5, 3-hydroxythiophenol and triethylamine is 1:(1.2-1.5):(1.2-1.5).
7. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (5), the molar ratio of compound 6 to concentrated hydrochloric acid is 1:(3-5), and the mass fraction of concentrated hydrochloric acid is 36-38%.
8. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (6), the molar ratio of compound 7, acetic anhydride and triethylamine is 1:(1.2-1.5):(1.2-1.5); In step (7), the molar ratio of compound 4, compound 8, HATU and DIPEA is 1:(1.1-1.2):(1.5-2):(2-3).
9. The method for preparing the NIRF / PA dual-modality probe based on NTR response according to claim 2, It is characterized in that In step (8), the molar ratio of compound 9 to concentrated hydrochloric acid is 1:(3-5), and the mass fraction of concentrated hydrochloric acid is 36-38%; In step (9), the molar ratio of the dye, p-nitrobenzyl bromide, potassium carbonate and sodium iodide is 1:(1.1-1.3):(1.5-2):(2-3).
10. Use of the NIRF / PA dual-modality probe based on NTR response according to any one of claims 1 to 9, It is characterized in that It is used to detect NTR in samples, cells, tissues, and living mice.
Citation Information
Patent Citations
Probe capable of realizing two-photon fluorescence detection of nitroreductase (NTR) and preparation method thereof
CN108727223A
Double-ratio type hemicyanine dye molecule as well as synthesis method and application thereof
CN113278304A
Near-infrared fluorescent probe for rapidly detecting nitroreductase as well as preparation and application of near-infrared fluorescent probe
CN116925025A
Nitroreductase fluorescent probe as well as preparation method and application thereof
CN117164502A
Hydrolysis-resistant esters for drug and imaging agent delivery
US20240158359A1
